🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
SAFIR PI3K is an open-label multicenter phase II randomized trial, comparin...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2018-03-15
Trial ID
NCT03386162
Treatments Being Tested
A randomized, double-blind, multicenter phase III clinical study to evaluat...
Status
Not Yet Recruiting
Location
Clinical Trials Information Group
Start Date
2025-04
Trial ID
NCT06929325
This is a prospective, single arm phase II study to evaluate the efficacy a...
Status
Unknown
Location
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
Start Date
2013-11
Trial ID
NCT02000193
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
The goal of this clinical trial is to evaluate if KSHN001034 demonstrates s...
Status
Recruiting
Location
Floridian Clinical Research LLC
Start Date
2025-08-18
Trial ID
NCT06995482
Treatments Being Tested
This research study will test whether dual anti-estrogen therapy (anastrozo...
Status
Terminated
Location
University of Pittsburgh Cancer Institute
Start Date
2010-09
Trial ID
NCT00932152
Treatments Being Tested
The trial used a multicenter, open, single-arm design in which patients wer...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-07
Trial ID
NCT05191914
Treatments Being Tested
This is a dose-escalation Phase Ib clinical trial in 18 patients with newly...
Status
Unknown
Location
California Research Institute
Start Date
2016-01
Trial ID
NCT02626507
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of CDK4/6 inhi...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-09-13
Trial ID
NCT04526028
Treatments Being Tested